Farmila-Thea Farmaceutici is a finished-dose manufacturer based in Italy. It appears in 5 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE) and UZPHARM (UZ). Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 27 January 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Settimo Milanese (MI), United Arab Emirates | Not on file |
| SETTIMO MILANESE, Italy | Not on file |
| Settimo Milanese, Italy | Not on file |
| Italy, Italy | 3004438462 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 4 | None |
| UZPHARM (UZ) | 1 | None |
| EMA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Farmila-Thea Farmaceutici comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.